|
|
|
|
| LEADER |
03509nmm a2200385 u 4500 |
| 001 |
EB002008341 |
| 003 |
EBX01000000000000001171241 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
220104 ||| eng |
| 020 |
|
|
|a 9789811669217
|
| 100 |
1 |
|
|a Nandy, Mithun
|
| 245 |
0 |
0 |
|a Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry
|h Elektronische Ressource
|c by Mithun Nandy
|
| 250 |
|
|
|a 1st ed. 2022
|
| 260 |
|
|
|a Singapore
|b Palgrave Macmillan
|c 2022, 2022
|
| 300 |
|
|
|a XXXI, 202 p. 25 illus., 20 illus. in color
|b online resource
|
| 505 |
0 |
|
|a Chapter 1. Introduction -- Chapter 2. A Profile of the Indian Pharmaceutical Companies -- Chapter 3. Marketing Activities of Indian Pharmaceutical Companies -- Chapter 4. Research and Development Activities of the Indian Pharmaceutical Companies -- Chapter 5. Global Competitiveness of Indian Pharmaceutical Companies -- Chapter 6. Evaluation of Financial Performance in the Global Context -- Chapter 7. Empirical Study
|
| 653 |
|
|
|a Business
|
| 653 |
|
|
|a Business intelligence
|
| 653 |
|
|
|a Financial statements
|
| 653 |
|
|
|a Asian Business
|
| 653 |
|
|
|a Asia
|
| 653 |
|
|
|a Market Research and Competitive Intelligence
|
| 653 |
|
|
|a Asia / Economic conditions
|
| 653 |
|
|
|a Sector and Industry Studies
|
| 653 |
|
|
|a Financial Reporting
|
| 653 |
|
|
|a Asian Economics
|
| 653 |
|
|
|a Marketing research
|
| 653 |
|
|
|a Industries
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 028 |
5 |
0 |
|a 10.1007/978-981-16-6921-7
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-981-16-6921-7?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 338
|
| 520 |
|
|
|a The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach. Dr. Mithun Nandy has over 16 years of pharmaceutical industry experience and is currently designated as Assistant General Sales Manager in Hegde & Hegde Pharmaceutica LLP, Mumbai, India. He is responsible for the different domestic and international market operations at H&H which are connected to pharmaceutical product promotion and selling. He has presented numerous research papers and posters at different national and international management conferences. He has a good number of empirical research papers published in various reputable peer-reviewed international journals. His professional success story has been featured in IQVIA Sales View.
|